BioSpace News Archive

Akari Therapeutics, Plc today announced that the company will participate in the Ophthalmology Day at BTIG on November 29, 2022.

Inhibikase Therapeutics, Inc. today announced that Milton Werner , Ph.D., President and Chief Executive Officer of Inhibikase, will present at the Piper Sandler 34th Annual Healthcare Conference being held on November 29 – December 1, 2022, in New York, NY.

LENSAR, Inc. today announced Nick Curtis, Chief Executive Officer will present at two upcoming investor conferences.

NextGen Healthcare to Participate in the Piper Sandler 34th Annual Healthcare Conference.

OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced the publication of preclinical research on the androgenetic alopecia (hair loss) treatment program, OLX104C, in Molecular Pharmaceutics.

VBI Vaccines Inc. today announced that additional biomarker data from the Phase 1/2a study of VBI-1901, the Company’s cancer vaccine immunotherapeutic candidate in recurrent glioblastoma (GBM), were presented at the 27th Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO), on Friday, November 18, 2022.

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present virtually at the 5th Annual Evercore ISI HealthCONx Conference on Tuesday, November 29, 2022, at 2:40 p.m. Eastern Time.

For the first time, data linking COVID long hauler symptoms to autonomic nervous system dysfunction or dysautonomia was recently presented at the annual American College of Rheumatologists Conference on Sunday, November in Philadelphia, Pennsylvania.

AbbVie will participate in the Piper Sandler 34th Annual Healthcare Conference on Thursday, December 1, 2022.

Qualigen Therapeutics, Inc., a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, while also commercializing diagnostics, announces that its board of directors has approved a 1-for-10 reverse stock split of the Company’s common stock.